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Temporal profile of body temperature in acute
ischemic stroke: relation to stroke severity and
outcome
Bartosz Karaszewski1,2, Ralph GR Thomas1,3, Martin S Dennis1 and Joanna M Wardlaw1,3*
Abstract
Background: Pyrexia after stroke (temperature ≥37.5°C) is associated with poor prognosis, but information on
timing of body temperature changes and relationship to stroke severity and subtypes varies.
Methods: We recruited patients with acute ischemic stroke, measured stroke severity, stroke subtype and recorded
four-hourly tympanic (body) temperature readings from admission to 120 hours after stroke. We sought causes of
pyrexia and measured functional outcome at 90 days. We systematically summarised all relevant previous studies.
Results: Amongst 44 patients (21 males, mean age 72 years SD 11) with median National Institute of Health Stroke
Score (NIHSS) 7 (range 0–28), 14 had total anterior circulation strokes (TACS). On admission all patients, both TACS
and non-TACS, were normothermic (median 36.3°C vs 36.5°C, p=0.382 respectively) at median 4 hours (interquartile
range, IQR, 2–8) after stroke; admission temperature and NIHSS were not associated (r2=0.0, p=0.353). Peak
temperature, occurring at 35.5 (IQR 19.0 to 53.8) hours after stroke, was higher in TACS (37.7°C) than non-TACS
(37.1°C, p<0.001) and was associated with admission NIHSS (r2=0.20, p=0.002). Poor outcome (modified Rankin Scale
≥3) at 90 days was associated with higher admission (36.6°C vs. 36.2°C p=0.031) and peak (37.4°C vs. 37.0°C,
p=0.016) temperatures. Sixteen (36%) patients became pyrexial, in seven (44%) of whom we found no cause other
than the stroke.
Conclusions: Normothermia is usual within the first 4 hours of stroke. Peak temperature occurs at 1.5 to 2 days
after stroke, and is related to stroke severity/subtype and more closely associated with poor outcome than
admission temperature. Temperature-outcome associations after stroke are complex, but normothermia on
admission should not preclude randomisation of patients into trials of therapeutic hypothermia.
Keywords: Ischemic stroke, Tympanic body temperature, Pyrexia, Outcome, OCSP
Background
Elevated body temperature (pyrexia) is said to be common
after stroke [1,2] and is associated with poor outcome
[2-10]. However, the timing of pyrexia after stroke varied
between studies (Table 1). Pyrexia occurring early might
reflect the systemic response to ischemic brain damage
[11] whereas pyrexia occurring later might be due to com-
plications of severe stroke, such as infection and deep
venous thrombosis (DVT). However data on timing,
causes and associations between body temperature and
outcome vary.
Amongst the 18 previous studies of temperature
after stroke (Tables 1 and 2), four performed only one
temperature recording [3,6,12,20], some measured
temperature at admission but relatively late (e.g. 24 hours)
[11] or at unspecified times after stroke [2,4,7]. Where
serial readings were obtained, this was only up to three
days after stroke [8,9,13,15,18,22]. Six studies included
haemorrhagic and ischemic stroke [2-4,6,12,19]. Defini-
tions of pyrexia, temperature measurement methods,
reporting of associations with stroke severity and of
causes of pyrexia varied widely [2,7,10,14,16,17,21].
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Table 1 Previous studies of body temperature and outcome after stroke - methods
First author
and year
Study
design
N Types of stroke Temperature
measurement
method
Time of 1st;
interval;
last reading
Statistical analysis Outcome measures Definition of
pyrexia
Azzimondi
1995 [2]
P 183 Any stroke <48 hrs (not
SAH)
A N/S; 12 h; 7 d Max temp in 7 d, logistic regression CNS, serial GCS up to 30 d, 1, 3 &
6 month Barthel
≤37.2 = absence
of fever. ≥37.9 =
high fever
Reith 1996 [3] P 390 Any stroke <6 hrs T <6 h; -; - Logistic regression Lesion size, SSS, presence of
infection, WCC
>37.5
Castillo 1998
[9]
P 297 Ischaemic A <24 h; 2 h; 72 h Correlate peak temp with clinical
outcome and final infarct vol. Stepwise
logistic regression
CSS, presence of infection, 4–7 d
lesion volume, 3 month Barthel
>37.5
Georgilis 1999
[4]
R 330 Any stroke Most A, some
RC
<48 h; 3 h; - Presence/absence of fever and infection.
Stepwise logistic regression
GCS, SSS, CT lesion volume,
presence of infection, use of
invasive procedures
>37.5 on >2
occasions on 2
consec. days
Wang 2000 [12] R 437 Any “acute” stroke T “Admission” but
no time limit
given; -; -
Logistic regression. ischaemic vs.
haemorrhagic stroke
Co-morbidities, WCC, [glucose],
mortality (in-hospital and 1 yr)
>37.5
Boysen 2001 [8] P 584 Ischaemic T <6 h; 2–4 h; 48
h
Mean temp analysis by subgroup SSS, 3 month mRS >37.5
Kammersgaard
2002 [6]
P 390 Any stroke T <6 h; -; - Dichotomised normothermia vs. pyrexia,
and multivariate survival analysis
SSS, [glucose], 5 yr mortality >37
Audebert 2004
[13]
R 346 Ischaemic; Excl pts with
infection pre- or post-
stroke
O or RC <24 h (mean
6.7 h); 2–12 h; 3
d
Subgroup analysis of median temp days
1-3
NIHSS, WCC, CRP, 1–5 d lesion
volume (CT/MR)
≥37.5
Sulter 2004 [1] P 132 Ischaemic; Excl pts on
antibiotics on admission
RC <12 h;
continuous; 48
h
Dichotomised according to hyperthermia
or not within 48 h
baseline NIHSS, presence of
infection, effect of antipyretics
>37.5
Ernon 2006 [14] R 107 Ischaemic, with thrombo-
lysis
T/O <180 mins;
random; 24 h;
AUC relative to 37° and to baseline T° NIHSS, 3 month mRS >37.4
Leira 2006 [11] P 229 First ischaemic; Excl pts
with inflammatory or
infectious disease
A <24 h; -; - Presence vs. absence baseline pyrexia CSS, BP, blood biochemistry, 4–7
d lesion volume (CT)
≥37.5
Wong 2007 [15] P 156 Ischaemic T <48 h (median
2.5 h); 4 h; 48 h
Mixed model, Lowess curves Baseline NIHSS, use of
paracetamol, presence of
infection
None
Idicula 2008
[16]
P 127 Ischaemic with thrombo-
lysis
N/S <3 h; random; 5
d
Pre-thombolysis temperature and peak
temperature in 5 d
NIHSS, 3 month mRS, BP, peak
[glucose]
>37.7
Millan 2008
[17]
R 254 Ischaemic stroke with
thrombolysis
N/S <3 h; 6 h; 48 h Pre-thrombolysis, temperature at 24 and
48 h, and peak temperature within 24 h
post- thrombolysis
NIHSS, 3 month mRS, early lesion
vol (CT), MCA TIBI score (TCD)
≥37
Saini 2009 [7] R 5305 First ischaemic Most patients:
A; others N/S
N/S; 8 then 24
hrly; 7 d
Normotherm vs. pyrexia at different time
points
WCC, NIHSS, 3 month mRS, lesion
vol (1–7 d CT/MR), use of
antibiotics
>37.2
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Table 1 Previous studies of body temperature and outcome after stroke - methods (Continued)
den Hertog
(PAIS) 2009 &
2011 [18,19]
P RCT 1399or
1332
Any stroke <12 hrs T or RC median 6 h, all
<12 h; -; -
Multiple logistic regression baseline NIHSS, 14 d Barthel, 3
month mRS
None
Naess 2010 [20] R 250
(111 vs.
139)
Ischaemic N/S < 6 h; -; - Logistic regression, temperature against
outcome in tPA-treated vs. non-treated
patients
baseline NIHSS, mRS on day 7 or
at discharge, vascular risk factors,
stroke aetiology
None
Phipps 2011
[21]
R 1361 Ischaemic, NIHSS ≥ 2 Majority – T,
partially
unknown
<48 h; -; - Logistic regression vascular risk factors, NIHSS, stroke
aetiology
≥37.8
P: prospective; SAH: subarachnoid haemorrhage; A: axillary; N/S: not specified; h: hours; d: days; CNS: Canadian Neurological Scale; GCS: Glasgow Coma Score; T: tympanic; SSS: Scandinavian Stroke Scale Score; WCC:
white cell count; CSS: Canadian Stroke Scale; R: retrospective; RC: rectal; CT: computed tomography; mRS: modified Rankin Score; O: oral; NIHSS: National Institutes of Health Stroke Scale; CRP: C reactive protein; MR:
magnetic resonance; AUC: area under the curve; BP: blood pressure; MCA: middle cerebral artery; TIBI: thrombolysis in brain ischaemia; TCD: transcranial Doppler; tPA: tissue plasminogen activator.
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Thus, while some studies found associations between
higher admission temperature and poor outcome (Table 2)
[3,6,12], others found that peak temperature occurring
several days after stroke, not admission temperature, was
associated with poor outcome [7,16,17,19]. The reasons
for these differences are unclear but important to under-
stand to limit brain damage and improve outcome after
stroke.
We obtained measurements of body temperature every
four hours from admission to five days after acute ische-
mic stroke as part of a study to examine serial changes
in the ischaemic lesion on MR imaging. We used these
data to clarify the temporal profile, associations with
stroke severity, subtype and functional outcome and
proportion with an alternative explanation for pyrexia.
Methods
We prospectively recruited patients >18 years old who
presented with potentially disabling ischemic stroke. We
excluded patients with intracerebral haemorrhage (ICH),
coma, serious intercurrent illness, and technical or clin-
ical incompatibility with MR scanning. Ethical approval
was granted by the Scottish Multi-Centre Research Ethics
Committee (06/MRE00/119) and we obtained informed,
written consent from all patients or their relatives.
At admission, we recorded National Institute of Health
Stroke Score (NIHSS) and the Oxford Community
Stroke Project (OCSP) stroke subtype classification [23].
All patients underwent MR imaging to diagnose the is-
chemic stroke. We recorded temperature using a First
Temp GeniusW tympanic thermometer immediately on
Table 2 Previous studies of body temperature and outcome after stoke – key results
First author and year Key findings
Azzimondi 1995 [2] High fever (≥37.9°C) <7 d is independent risk factor for poor prognosis. Fever occurred in 43% of stroke pts <7 d.
Onset of fever occurred in first 2 days in 64% of febrile patients.
Reith 1996 [3] Admission body temp is independently related to stroke severity, lesion size, mortality and outcome. [unclear how
measured “outcome”; didn’t separate AIS from ICH]
Castillo 1998 [9] The relationship between the degree of hyperthermia and stroke outcome/FIV is strongest when it begins within
24 h of symptom onset.
Georgilis 1999 [4] Fever in stroke is assoc with ↑age, ↑severity, more invasive techniques, worse outcome. When fever present
without focus of infection, it tends to occur earlier.
Wang 2000 [12] For ischaemic stroke, admission temp (time unspecified) was significant predictor of in-hospital mortality: for each
1° increase, OR ↑ by 3.9 (CI 1.9 to 7.8, p<0.001).
Boysen 2001 [8] Temp < 6 h post stroke onset has no prognostic influence on 3 month mRS. More severe strokes have higher
temperature in first 48 h. [Also looked at ICH]. 7 d fatality rate higher in patients with lower body temp on
admission.
Kammersgaard 2002 [6] For all strokes, a 1° difference in admission body temperature gives 30% increase in relative risk of 5 yr mortality.
No association between admission temp and survival in pts still alive at 3 months.
Audebert 2004 [13] Larger stroke volume and greater NIHSS assoc with higher temp, CRP and WCC. Successful thrombolysis attenuates
inflammatory response
Sulter 2004 [1] 56% developed hyperthermia in 1st 48 h. Infectious cause found in 1/3 of patients.
Ernon 2006 [14] Hyperthermia relative to baseline in 24 h (post rtPA) is assoc with unfavourable outcome
Leira 2006 [11] Hyperthermia assoc with higher levels of proinflammatory markers. Inflammatory mediators play a role in acute
ischaemic brain damage independently of hyperthermia
Wong 2007 [15] Mean temp rise in first 24 h from 36.5 to 36.7°, peak at 36 h. More severe strokes have higher temp rise.
Idicula 2008 [16] Body temp before thrombolysis was not assoc with 3 month outcome, but high temp thereafter was.
Millan 2008 [17] Body temp ≥37 at 24 h but not at baseline was assoc with lack of recanalisation, greater hyperdensity volume and
worse functional outcome, regardless of stroke severity and time to treatment
Saini 2009 [7] Hyperthermia assoc with poor outcome. Delayed hyperthermia is more strongly assoc with poor outcomes than
early hyperthermia. No association between baseline hyperthermia and outcome.
den Hertog (PAIS) 2009 &
2011 [18,19]
Baseline body temp was not related to improvement. Increased body temp at 24 h was associated with low
likelihood of improvement.
Naess 2010 [20] High body temperature was associated with favorable short-term outcome in those who were thrombolysed vs.
those not thrombolysed
Phipps 2011 [21] High “fever burden” (combination of fever height and duration) was associated with death or with referral to
hospice
d: days; AIS: acute ischemic stroke; ICH: intracerebral haemorrhage; FIV: final infarct volume; h: hours; OR: odds ratio; CI: confidence interval; mRS: modified Rankin
Score; NIHSS: National Institutes of Health Stroke Scale; CRP: C reactive protein; WCC: white cell count; rtPA: recombinant tissue plasminogen activator.
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arrival at hospital, and four hourly thereafter up to 120
hours. Recordings were taken from the uppermost ear in
most patients, and from both ears in 11 patients to test
side-to-side variation [24]. Tympanic thermometry is
considered reliable for serial readings [25], shows the
least variation with age compared with axillary, rectal
and oral thermometry [26], and is widely used in clinical
practice. Pyrexia was defined as temperature ≥37.5°C
[10]. We searched for causes of pyrexia by collecting
data on evidence of infection (evident infectious agent,
leukocytes in body fluid, signs on imaging), DVT and
surgical intervention as well as paracetamol and anti-
biotic use. Our policy is to prescribe paracetamol to
patients who develop pyrexia (or for other indications
such as pain relief) and antibiotics when positive evidence
of infection and an infectious agent is diagnosed. We
recorded modified Rankin Scale score (mRS) at three
months after stroke, blind to temperature measurements.
We compared admission, peak and final temperatures
and calculated area under the temperature/time curve
(AUC)[27] which we standardised (AUC[s]) by assuming
all patients had a temperature of 36.5°C between stroke
and the admission recording, and dividing AUC by the
time of final temperature reading [27]. We tested the as-
sociation between temperature profile and measures of
stroke severity firstly as determined by NIHSS, secondly
by comparing total anterior circulation strokes (TACS)
vs. less severe stroke subtypes (non-TACS) and thirdly
good (mRS ≤2) vs. poor (mRS≥3) 90 day outcome. We
adjusted analysis for age and admission NIHSS where
appropriate. We used Student’s t-test for parametric and
Mann Whitney U tests and Spearman correlation for
non-parametric data.
Results
Between 7th December 2007 and 24th March 2009, we
recruited 48 patients but excluded two with ICH, one
with complex migraine and one with functional limb
weakness, leaving 44 with acute ischemic stroke (21
males) of median age 74 years (range 37–88) and me-
dian admission NIHSS 7 (range 0–28). There were 14
TACS and 30 non-TACS (Table 3). Twenty-five patients
had poor (mRS≥3) and 19 had good (mRS≤2) 90 day
functional outcomes. Patients with poor outcome were
older (75±10) with higher admission NIHSS (13±7) than
patients with good outcome (68±11 and 5±4 respectively).
There was no difference between ipsi- and contralat-
eral tympanic temperature readings obtained simul-
taneously (36.6°C vs 36.6°C, 95% confidence interval
(CI) -0.19 to 0.16, p=0.821) in 11 patients (five TACS).
The mean number of temperature readings per patient
was 14 (SD 6.9). No patients died during the observa-
tion period.
When temperature was first measured on admission,
at a median 4 (interquartile range (IQR) 2 to 7.8) hours
after stroke, all patients were normothermic (mean
36.4°C, 95% CI 36.2 to 36.6) (Table 3). Peak tem-
perature (mean 37.3°C, 95% CI 37.1 to 37.5) occurred
at median 35.5 hours (IQR 19.0-53.8) after stroke. The
latest temperature (mean 36.5°C, 95% CI 36.3 to 36.7)
was recorded at median 108.5 hours (IQR 98.8-113.5)
after stroke.
Admission NIHSS score was not associated with ad-
mission temperature (adjusted r2=0.0, p=0.353), but was
associated with peak (adjusted r2=0.20, p=0.002), and
final (adjusted r2=0.25, p=0.001) temperatures. NIHSS
was also associated with the overall temperature profile
AUC[s] (adjusted r2=0.07, p=0.047).
Admission temperature in TACS (mean 36.3°C, 95% CI
35.9-36.7) was similar to temperature in non-TACS
(36.5°C, 95% CI 36.3-36.6) patients (p=0.382), measured
at median 3.5 hours (IQR 1.0-6.0) in TACS, and 4 hours
(IQR 2.0-8.8) in non-TACS (p=0.258, Mann Whitney
U test), Table 4, Figure 1. However, peak temperature
was higher in TACS (mean 37.7°C, 95% CI 37.5-37.9)
than in non-TACS (37.1°C, 95% CI 36.9-37.3, p<0.001),
occurring at median 46.0 hours in TACS and 32.5
hours in non-TACS (p=0.199, Mann Whitney U test).
Final temperature was also higher in TACS (mean
36.8°C, 95% CI 36.6-37.0) than non-TACS (36.3°C, 95%
CI 36.1-36.6, p=0.002) patients, and occurred later in
TACS (median 117.5 hours, IQR 107.5-119.8) than in
non-TACS patients (107.5 hours, IQR 94.3-111.5,
p=0.007 Mann Whitney U test). Consequently, TACS pa-
tients had a larger AUC[s] (36.6, 95% CI 36.5-36.8) than
non-TACS patients (36.4, 95% CI 36.3-36.5, p=0.019). This
is demonstrated graphically in Figure 2. Detailed tempe-
rature profiles for TACS and non-TACS patients are pro-
vided in Additional file 1: Figure S1a and b.
Admission temperature was higher in the 25 patients
with poor outcome (36.6°C, 95% CI 36.3-36.8) than in
the 19 patients with good outcome (36.2°C, 95% CI
36.0-36.4, p=0.031) at 90 days. Peak temperature was
also higher in patients with poor outcome (37.4°C, 95%
CI 37.2-37.6) than in patients with good outcome, (37.0°C,
95% CI 36.8-37.3, p=0.016) (Figure 3). A higher propor-
tion of patients with pyrexia (12/16, 75%) had a poor
90 day outcome than did patients without pyrexia (13/28,
46%), odds ratio (OR) 3.46, 95% CI 0.89 to 13.39)
(Table 3).
Sixteen (36%) patients became pyrexial (at least one
temperature reading of ≥37.5°C) during the recording
period: 9/14 (64%) TACS patients and 7/30 (23%) non-
TACS (χ2=6.9, p=0.009). Of the 16 pyrexial patients, at
least one potential cause of pyrexia was identified in
nine (56%), but 11/16 (69%) had no infection and 7/16
(44%) had no identified cause for pyrexia (apart from the
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stroke). Conversely, a potential pyrogenic factor was iden-
tified in 7/28 (25%) patients without pyrexia (Table 3).
Thirteen patients were prescribed paracetamol of whom
seven were recorded as having pyrexia and six were not
(OR for pyrexia associated with paracetamol=1.8, 95% CI
0.48 to 6.77). The reason for paracetamol administration
in the patients without pyrexia was mostly for pain relief.
Ten patients with poor outcome (40%) had been prescribed
paracetamol but only in three (16%) patients with good out-
come (OR for poor outcome 3.56, 95% CI 0.82 to 15.46).
Table 4 Mean admission, peak and final body temperatures in patients grouped according to OCSP classification
Stroke subtype
(OCSP)
n Admission temperature °C
(95% CI)
Peak temperature °C
(95% CI)
Final temperature °C
(95% CI)
90 day mRS 0 to
2 (n)
90 day mRS 3 to
6 (n)
TACS 14 36.3 (35.9-36.7) 37.7 (37.5-37.9) 36.8 (36.6-37.0) 2 12
PACS 19 36.4 (36.2-36.6) 37.0 (36.8-37.3) 36.3 (36.0-36.7) 11 8
LACS 6 36.7 (36.4-36.9) 37.0 (36.7-37.2) 36.2 (36.0-36.3) 3 3
POCS 5 36.6 (35.8-37.4) 37.3 (36.5-38.1) 36.5 (36.0-36.9) 3 2
Total 44 36.4 (36.3-36.6) 37.3 (37.1-37.4) 36.5 (36.3-36.7) 19 25
OCSP: Oxford Community Stroke Project; CI: confidence interval; TACS: total anterior circulation stroke; PACS: partial anterior circulation stroke; LACS: lacunar
stroke; POCS: posterior circulation stroke; mRS: modified Rankin Score.
Table 3 Baseline data, pyrogenic factors and use of antibiotics and thrombolysis
Total n=44 No pyrexia n=28 Pyrexia n=16
Sex
Male 21 15 6
Female 23 13 10
Mean Age in years, (SD) 71.9 (11.4) 71.9 (11.7) 71.9 (11.3) p=0.990
Stroke Subtype
TACS 14 5 9 TACS vs
PACS 19 14 5 non-TACS
LACS 6 6 0 χ2=6.9
POCS 5 3 2 p=0.009
Stroke severity
Median NIHSS (IQR) 7 (3–14) 6.5 (3–10) 12 (5–18) p=0.0381 (MWU)
Temperature
Time to peak, median hours
after stroke, (IQR)
35.5 (19–53.8) 36.0 (7.8-59.3) 32.5 (22.8-51.3) p=0.652 (MWU)
No. with ≥1 pyrogenic factor identified* 16 (36%) 7 (25%) 9 (56%)
Urinary catheter 8 3 5
NG tube 9 4 5
Surgical procedure 4 2 2
DVT 0 0 0
Infection: urinary 2 0 2
Infection: respiratory 7 4 3
Antibiotics 10 4 (14%) 6 (38%)
Paracetamol 13 7 (25%) 6 (38%)
Thrombolysis 3 1 (4%) 2 (13%)
90 day mRS
mRS ≤2 19 15 4 χ2=3.5
mRS ≥3 25 13 12 p=0.061
*Some patients had more than 1 potential cause of pyrexia. Pyrexia was defined as tympanic temperature ≥37.5°C. SD: standard deviation; TACS: total anterior
circulation stroke; PACS: partial anterior circulation stroke; LACS: lacunar stroke; POCS: posterior circulation stroke; NIHSS: National Institute of Health Stroke Score;
IQR: interquartile range; MWU: Mann Whitney U test; NG: nasogastric; DVT: deep venous thrombosis; mRS: modified Rankin Score.
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Discussion
In patients with ischemic stroke, tympanic temperature
was not elevated on admission even in patients with
more severe strokes (TACS), and admission temperature
did not correlate with admission NIHSS. Instead, we
found that peak temperature, occurring at around 1.5 to
2 days after stroke and overall temperature, as expressed
by AUC were associated with admission stroke severity as
measured by NIHSS and TACS subtype. Peak temperatures
were higher, occurred later and temperature elevation
lasted longer in more severe than less severe strokes
perhaps indicating a more prolonged, greater inflammatory
response to the volume of infarcted tissue. Patients with
poor functional outcome (mRS≥3) at 90 days had higher
admission and peak temperatures than patients with good
outcome (mRS≤2), although all admission temperatures
were <37°C. We were not able to find a source of infection
in 69% of pyrexial patients, and no alternative cause of pyr-
exia, other than the stroke itself, in 44%.
This prospective study of detailed four-hourly tym-
panic temperature measurements up to five days after
ischemic stroke helps explain the varying results of pre-
vious studies (Tables 1 and 2) some of which found
associations between admission temperature, stroke se-
verity and outcome [3,4,6,12,13], while others did not
[8,14,16,19]. This variation can be attributed to some
studies being retrospective, or not specifying the timing of
temperature recording after stroke, sampling temperature
only once, measuring “admission” temperature relatively
late after stroke, only measuring serial temperature up to
72 hours, the different severities of stroke included in each
study or including patients with both haemorrhagic and is-
chemic stroke. Consistent with our results, others showed
that patients with more severe strokes experience higher
peak temperatures [15], and that elevated temperature at
24 hours [14,17,19], 48 hours [8] or 7 days [7] after stroke
was more closely linked to poor outcome than admission
readings. Our detailed longitudinal findings also demon-
strate the higher, later and longer duration of temperature
elevation in more severe than less severe stroke, which per-
haps has not been appreciated previously.
Our study has limitations. The small sample size was
constrained by selection of patients for an MR imaging
study, but on the other hand it allowed very detailed
temperature monitoring. However, the range of stroke
severity was consistent with those that would be consid-
ered for trials of therapeutic hypothermia. A larger sam-
ple size would allow more adjustment for potential
confounders, and clarification of the significance of any
differences in timing of peak temperature readings, and
comparison of patients whose tympanic temperature
Figure 2 Body temperature profiles of patients with severe
stroke (TACS) and milder stroke (non-TACS). Mean temperatures
and 95% confidence intervals are shown for admission, peak and
final temperature readings, averaged across all patients.
Figure 1 Admission, peak and final temperature in TACS (n=14) and non-TACS patients (n=30).
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may have been affected by antibiotics and antipyretics,
although our results show that pyrexia was just as com-
mon in patients who were prescribed paracetamol as in
those who were not, in contrast to others’ results [15].
However paracetamol may have influenced the profile of
temperature change. Although our data on temperature
profile and stroke severity are consistent with five previ-
ous studies, we cannot exclude the possibility of an asso-
ciation between admission temperature and stroke
severity. The study strengths are the detailed four-hourly
tympanic temperature measurements for 120 hours after
ischemic stroke and the detailed comparison with
stroke subtype, severity and outcome. The duration of
temperature recording ensured that the peak temperature
was captured in both TACS and non-TACS.
Two other points raise questions for further study.
Admission temperature in the patients with more se-
vere strokes, ie TACS, was not higher than in patients
with milder strokes, as might have been expected.
Perhaps, by analogy with other serious acute illness,
the temperature in severe stroke may reflect severe
illness [28]. Secondly, why do patients with a poor
outcome have a marginally higher (but still nor-
mothermic) admission temperature, and while severe
stroke is associated with poor outcome, severe stroke is
not associated with admission temperature? This might be
explained at least in part by a possible cascade of events
suggested in experimental data. Increased temperature
opens the blood–brain barrier [29] which, in acute ische-
mia, would lead to increased extracellular oedema, more
infarct swelling, more restricted capillary flow in the ische-
mic tissue, less chance of reperfusion, all contributing to
increasing ischemic damage, swelling and leading to a
larger infarct around 48 hours [30], consolidating the
potential for tissue damage that was suggested by the
severe stroke symptoms at presentation, and consequently
leading to the poor outcome at 90 days. Longer duration
of temperature monitoring should be considered in future
research to improve understanding of temperature profiles
after stroke.
This interpretation, if true, raises some implications
for therapeutic hypothermia trials. Firstly, and paradox-
ically, patients may benefit the most from hypothermia
if it prevents the tissue cascade outlined above from
causing more tissue damage and should certainly not be
excluded from trials; thus cooling should be initiated as
early as possible and not influenced by the patient’s
admission temperature. However cooling may only pre-
vent worsening of damage, not actively salvage tissue
that is already at risk, so combinations of therapies to
salvage (e.g. thrombolysis) as well as to restrict progres-
sive new damage (e.g. hypothermia, if it works) may be
required. Secondly, if the main effect of hypothermia is
to reduce blood–brain barrier opening thus preventing
the cascade that leads to larger stroke lesions, then
hypothermia could still be valuable if started many
hours after the stroke when the possibility of salvaging
at risk tissue was lost but there was still some “future
secondary damage” to prevent. If correct, then hypo-
thermia should reduce subacute infarct oedema and
mass effect. Thirdly, if correct, then therapeutic thromb-
olysis and hypothermia should work synergistically to
produce greater benefit than either alone. However
hypothermia may also have some disadvantages. In
addition to increased risk of secondary infection and the
need to manage unpleasant side effects like shivering,
lower temperatures might delay thrombus lysis which
pyrexia might accelerate. The balance of risk and benefit
presented by these possibilities requires testing in future
therapeutic trials of hypothermia after stroke.
Figure 3 Admission, peak and final temperature by 90 day outcome (mRS ≤2, n=19; mRS ≥3, n=25).
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Conclusion
The association between body temperature, stroke sever-
ity and functional outcome is complex and, if our obser-
vations in this small detailed study are verified, then
even very marginal differences in admission temperature
in normothermic patients may provide a mechanism
whereby, for a given stroke severity, potential tissue
damage is converted into more severe damage resulting
in a poor outcome, which might be prevented by thera-
peutic hypothermia.
Additional file
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